Pavel Balaban

Dr. Pavel Balaban

orcid

Research Focus & Metrics

Academic Career Length

54Years (1973-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
PBPavel Balaban
Pavel Balaban

1 November 2015 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
MMMikhail E. Matlashov
Mikhail E. Matlashov
YBYulia A. Bogdanova
Yulia A. Bogdanova
GEGalina V. Ermakova
Galina V. Ermakova
NMNatalia M. Mishina
Natalia M. Mishina
YEYulia Ermakova
Yulia Ermakova
VBVsevolod Belousov
Vsevolod Belousov

11 November 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MSMaria Suntsova
Maria Suntsova
EGElena V. Gogvadze
Elena V. Gogvadze
SSSergey Salozhin
Sergey Salozhin
NGNurshat Gaifullin
Nurshat Gaifullin
FEFedor Eroshkin
Fedor Eroshkin
Anton BuzdinAnton Buzdin
Anton Buzdin
Significance: We identified a human-specific endogenous retroviral insert (hsERV) that acts as an enhancer for humanPRODH, hsERV_PRODH.PRODHencodes proline dehydrogenase, which is involved in neuromediator synthesis in the CNS. We show that the hsERV_PRODH enhancer acts synergistically with the CpG island ofPRODHand is regulated by methylation. We detected highPRODHexpression in the hippocampus, which was correlated with the undermethylated state of this enhancer.PRODHregulatory elements provide neuron-specific transcription in hippocampal cells, and the mechanism of hsERV_PRODH enhancer activity involves the binding of transcriptional factor SOX2. BecausePRODHis associated with several neurological disorders, we hypothesize that the human-specific regulation ofPRODHby hsERV_PRODH may have played a role in human evolution by upregulating the expression of this important CNS-specific gene.

1 February 1987 in Brain Research
Verified
Journal Article
Closed access
PBPavel Balaban
Pavel Balaban
ÁVÁgnes Vehovszky
Ágnes Vehovszky
OMOlga A. Maximova
Olga A. Maximova
IZIgor S. Zakharov
Igor S. Zakharov

1 July 1993 in Progress in Neurobiology
Verified
Journal Article
Closed access
PBPavel Balaban
Pavel Balaban

1 November 2005 in Learning & Memory
Verified
Journal Article
Open access
PDF file
TGTatiana H. Gainutdinova
Tatiana H. Gainutdinova
RTRosa R. Tagirova
Rosa R. Tagirova
AIAsja I. Ismailova
Asja I. Ismailova
LMLyudmila N. Muranova
Lyudmila N. Muranova
ESElena I. Samarova
Elena I. Samarova
PBPavel Balaban
Pavel Balaban
We investigated the influence of the protein synthesis blocker anisomycin on contextual memory in the terrestrial snail Helix. Prior to the training session, the behavioral responses in two contexts were similar. Two days after a session of electric shocks (5 d) in one context only, the context conditioning was observed as the significant difference of behavioral response amplitudes in two contexts. On the day following testing of context learning, a session of “reminding” was performed, immediately after which the snails were injected with anisomycin or vehicle. Testing of long-term context memory has shown that only anisomycin injections impaired the context conditioning. In control series, the snails were injected after the training session with anisomycin/saline without reminding, and no impairment of the long-term context memory was observed, while injection of anisomycin during the training session completely abolished the long-term memory. No effects of anisomycin on the short-term memory were observed. Surprisingly, injection of anisomycin after the reminding combined with reinforcing stimuli elicited no effect on the context memory. Differences between single-trial and multisession learning are discussed.